Hallucinogen -Related Disorder
Assignment: Treatment of Substance-Related and Addictive Disorders
Save your time - order a paper!
Get your paper written from scratch within the tight deadline. Our service is a reliable solution to all your troubles. Place an order on any task and we will take care of it. You won’t have to worry about the quality and deadlinesOrder Paper Now
Hallucinogen -Related Disorders
- Explain the diagnostic criteria for your assigned substance-related and addictive disorder ( Hallucinogen related disorder).
- Explain the evidenced-based psychotherapy and psychopharmacologic treatment for your assigned substance-related and addictive disorder.
- Describe clinical features that you would expect to observe in a client that may have the substance-related and addictive disorder you were assigned. Align the clinical features with the DSM-5 criteria.
- Support your rationale with references to the Learning Resources or other academic resources.
Required Readings( Need 3 + reference).
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.
Sadock, B. J., Sadock, V. A., & Ruiz, P. (2014). Kaplan & Sadock’s synopsis of psychiatry: Behavioral sciences/clinical psychiatry (11th ed.). Philadelphia, PA: Wolters Kluwer.
· Chapter 20, “Substance Use and Addictive Disorders” (pp. 616–693)
Stahl, S. M. (2017). Prescriber’s Guide: Stahl’s Essential Psychopharmacology (6th ed.). New York, NY: Cambridge University Press.
To access information on specific medications, click on The Prescriber’s Guide, 6th Ed. tab on the Stahl Online website and select the appropriate medication.
Reversal of benzodiazepine effects
Note: For more information about buprenorphine, see https: //www.samhsa.gov/medication-assisted-treatment/qualify-nps-pas-waivers
Note: The approximate length of this media piece is 69 minutes.
Note: The approximate length of this media piece is 126 minutes.
Bechtold, J., Simpson, T., White, H. R., & Pardini, D. (2015). Chronic adolescent marijuana use as a risk factor for physical and mental health problems in young adult men. Psychology of Addictive Behaviors, 29(3), 552–563. doi:10.1037/adb0000103
Note: You will access this article from the Walden Library databases.
Borchardt, D. (2017). National Academy of Sciences pushes for rescheduling of marijuana. Forbes. Retrieved from https://www.forbes.com/sites/debraborchardt/2017/01/18/national-academy-of-sciences-suggests-removing-barriers-to-cannabis-research-basically-deschedule/#22269c753f76
Gabbard, G. O. (2014). Gabbard’s treatment of psychiatric disorders (5th ed.). Washington, DC: American Psychiatric Publications.
· Chapter 46, “Alcohol-Related Disorders”
· Chapter 47, “Sedative-, Hypnotic-, or Anxiolytic-Related Disorders”
· Chapter 48, “Opioid-Related Disorders: Opioid Detoxification”
· Chapter 49, “Opioid-Related Disorders: Antagonist Treatment”
· Chapter 50, “Opioid-Related Disorders: Agonist Maintenance Treatment”
· Chapter 51, “Hallucinogen-Related Disorders
· Chapter 52, “Cannabis-Related Disorders”
· Chapter 53, “Club Drug Addiction”
· Chapter 54, “Stimulant-Related Disorders”
· Chapter 55, “Nicotine-Related Disorders”
· Chapter 56, “Individual Therapy for Substance Use Disorders”
· Chapter 57, “Cognitive, Behavioral, and Motivational Therapies for Substance Use Disorders”
· Chapter 58, “Group Therapy for Substance Use Disorders”
· Chapter 59, “Family Therapy in Substance Abuse Treatment”
· Chapter 60, “Network Therapy for Substance Use Disorders”
· Chapter 61, “Pain and Addiction”
· Chapter 62, “Gambling Disorder”
Substance Abuse and Mental Health Services Administration (SAMHSA). (2013b). TIP 42: Substance abuse treatment for persons with co-occurring disorders. Retrieved from http://store.samhsa.gov/product/TIP-42-Substance-Abuse-Treatment-for-Persons-With-Co-Occurring-Disorders/SMA13-3992
Substance Abuse and Mental Health Services Administration (SAMHSA). (2013b). TIP 48: Managing depressive symptoms in substance abuse clients during early recovery. Retrieved from http://store.samhsa.gov/product/TIP-48-Managing-Depressive-Symptoms-in-Substance-Abuse-Clients-During-Early-Recovery/SMA13-4353